<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="95" ids="53371">PFA</z:chebi>-100 device is a new instrument for the in-vitro testing of platelet function </plain></SENT>
<SENT sid="1" pm="."><plain>Primary haemostasis is stimulated by recording the closure time taken for platelets to seal a 150 microm aperture in the centre of a membrane coated with collagen and either <z:chebi fb="2" ids="28918">epinephrine</z:chebi> or <z:chebi fb="13" ids="16761">ADP</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with type 3 von <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">Willebrand's disease</z:e> (n = 4) <z:hpo ids='HP_0000001'>all</z:hpo> had infinitely prolonged closure times (&gt; 200 s) with both types of cartridge </plain></SENT>
<SENT sid="3" pm="."><plain>A patient with <z:e sem="disease" ids="C0001733" disease_type="Disease or Syndrome" abbrv="">afibrinogenemia</z:e> exhibited only slightly prolonged closure times of 111 and 166 s for the <z:chebi fb="13" ids="16761">ADP</z:chebi> and <z:chebi fb="2" ids="28918">epinephrine</z:chebi> membranes, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with <z:e sem="disease" ids="C0235604" disease_type="Disease or Syndrome" abbrv="">Glanzmann</z:e>'s <z:hpo ids='HP_0004807'>thrombasthenia</z:hpo> (n = 6) and <z:e sem="disease" ids="C0005129" disease_type="Disease or Syndrome" abbrv="">Bernard Soulier syndrome</z:e> (n = 2) had grossly prolonged closure times (&gt; 200 s) with both types of cartridges </plain></SENT>
<SENT sid="5" pm="."><plain>These results confirmed that the <z:chebi fb="95" ids="53371">PFA</z:chebi>-100 system was highly dependent on <z:mpath ids='MPATH_458'>normal</z:mpath> <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor, <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> Ib and <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> IIb/IIIa levels but not on plasma fibrinogen </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with storage pool disease (n = 6) and <z:e sem="disease" ids="C0079504" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="HPS">Hermansky Pudlak syndrome</z:e> (n = 7) had prolonged closure times with the <z:chebi fb="2" ids="28918">epinephrine</z:chebi> cartridge </plain></SENT>
<SENT sid="7" pm="."><plain>There was no evidence of enhanced platelet function in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, in <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle-cell disease</z:e> or <z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>However, ingestion of aspirin resulted in a near consistent and significant prolongation of the closure time for the <z:chebi fb="2" ids="28918">epinephrine</z:chebi> cartridge but not for the <z:chebi fb="13" ids="16761">ADP</z:chebi> cartridge in both <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and patients </plain></SENT>
<SENT sid="9" pm="."><plain>The test offers a reliable, reproducible, rapid and simple means of assessing high-shear platelet function in vitro </plain></SENT>
</text></document>